The return of the prodigal son and the extraordinary development route of antibody TGN1412 ‐ lessons for drug development and clinical pharmacology

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2125|79|4|545-547

ISSN： 0306-5251

Source： BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.79, Iss.4, 2015-04, pp. : 545-547

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transporters in Drug Development and Clinical Pharmacology

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 94, Iss. 1, 2013-07 ,pp. : 3-9

John Wiley & Sons Inc

Access to resources Recommend Favorite

TGN-1412 and BIA-2474 Trials with Tragic End: Lessons Learnt To Make Clinical Trials Safer

By  

Reviews on Recent Clinical Trials, Vol. 13, Iss. 4, 2018-12 ,pp. : 252-256

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical pharmacology, creating current and future success in drug development

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 91-2700, Iss. 11, 2015-11 ,pp. : 1193-1197

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Pharmacology and the Catalysis of Regulatory Science: Opportunities for the Advancement of Drug Development and Evaluation

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 93, Iss. 6, 2013-06 ,pp. : 515-525

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical pharmacology, creating current and future success in drug development

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 11, 2015-11 ,pp. : 1193-1197

John Wiley & Sons Inc

Access to resources Recommend Favorite